Jefferies Financial Group Inc. Purchases Shares of 7,006 Globe Life Inc. $GL

Jefferies Financial Group Inc. acquired a new position in Globe Life Inc. (NYSE:GL) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,006 shares of the company’s stock, valued at approximately $1,252,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after purchasing an additional 607 shares during the period. NewEdge Advisors LLC increased its holdings in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in Globe Life by 11.5% in the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after buying an additional 58,163 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of Globe Life in the first quarter worth about $428,000. Finally, Focus Partners Wealth raised its position in shares of Globe Life by 8.3% in the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after acquiring an additional 656 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Trading Up 0.4%

Shares of GL stock opened at $173.41 on Monday. The stock’s fifty day moving average is $178.77 and its two-hundred day moving average is $159.66. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market capitalization of $13.33 billion, a P/E ratio of 11.51 and a beta of 0.48. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the company earned $3.05 EPS. Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is presently 8.76%.

Globe Life declared that its board has authorized a share buyback program on Monday, August 10th that authorizes the company to buyback $2.50 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 17.7% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. TD Cowen raised their target price on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company raised their price objective on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Piper Sandler lifted their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Jefferies Financial Group boosted their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. Finally, Morgan Stanley raised their price target on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and a consensus price target of $191.67.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the completion of the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. This represents a 15.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the sale, the chief executive officer owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. The trade was a 46.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 151,908 shares of company stock worth $27,239,981 in the last 90 days. 2.11% of the stock is owned by insiders.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.